Egetis Says Transaction Provides Access to ANI’s Rare Disease Platform
Egetis says the transaction enables it to leverage ANI’s rare disease platform and commercialization capabilities.
Egetis says the transaction enables it to leverage ANI’s rare disease platform and commercialization capabilities.